Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension

Background: Dobutamine stress echocardiography (DSE) has limited application in systemic sclerosis (SSc). We examined DSE usefulness in revealing pulmonary arterial hypertension (PAH) in selected SSc patients whose resting echocardiography for pulmonary hypertension (PH) was non-diagnostic. Methods:...

Full description

Bibliographic Details
Main Authors: Loukianos S. Rallidis, Konstantina Papangelopoulou, Georgios Makavos, Christos Varounis, Anastasia Anthi, Stylianos E. Orfanos
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/17/3972
_version_ 1797521175199350784
author Loukianos S. Rallidis
Konstantina Papangelopoulou
Georgios Makavos
Christos Varounis
Anastasia Anthi
Stylianos E. Orfanos
author_facet Loukianos S. Rallidis
Konstantina Papangelopoulou
Georgios Makavos
Christos Varounis
Anastasia Anthi
Stylianos E. Orfanos
author_sort Loukianos S. Rallidis
collection DOAJ
description Background: Dobutamine stress echocardiography (DSE) has limited application in systemic sclerosis (SSc). We examined DSE usefulness in revealing pulmonary arterial hypertension (PAH) in selected SSc patients whose resting echocardiography for pulmonary hypertension (PH) was non-diagnostic. Methods: Forty SSc patients underwent right heart catheterization (RHC) and, simultaneously, low-dose DSE (incremental doses up to 20 μg/kg/min). Inclusion criteria were: preserved left and right ventricular (RV) function (tricuspid annulus plane systolic excursion [TAPSE] ≥ 16 mm and tissue Doppler imaging-derived systolic velocity of tricuspid annulus [RVS’] > 10 cm/s), normal pulmonary function tests, and baseline maximal tricuspid regurgitation (TR) velocity of 2.7–3.2 m/s. Results: Of 36 patients who completed DSE, resting RHC diagnosed PAH in 12 patients (33.3%). At 20 μg/kg/min, patients with PAH had higher TR velocity, higher pulmonary arterial pressure measured by RHC, and lower RV inotropic response compared with patients without PAH. A cut-off value of maximal TR velocity >3.1 m/s had a sensitivity of 80%, a specificity of 84.2%, and an accuracy of 82.4% for the detection of PAH. Conclusions: Low-dose DSE has a satisfactory diagnostic accuracy for the early detection of PAH in highly selected SSc patients whose baseline echocardiographic measurements for PH lie in the gray zone.
first_indexed 2024-03-10T08:08:52Z
format Article
id doaj.art-800289ec871e4c288c853ad3a6e8ea49
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T08:08:52Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-800289ec871e4c288c853ad3a6e8ea492023-11-22T10:50:10ZengMDPI AGJournal of Clinical Medicine2077-03832021-09-011017397210.3390/jcm10173972Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary HypertensionLoukianos S. Rallidis0Konstantina Papangelopoulou1Georgios Makavos2Christos Varounis3Anastasia Anthi4Stylianos E. Orfanos5Second Department of Cardiology and Pulmonary Hypertension Clinic, Attikon Hospital, School of Medicine, National & Kapodistrian University of Athens, 16462 Athens, GreeceSecond Department of Cardiology and Pulmonary Hypertension Clinic, Attikon Hospital, School of Medicine, National & Kapodistrian University of Athens, 16462 Athens, GreeceSecond Department of Cardiology and Pulmonary Hypertension Clinic, Attikon Hospital, School of Medicine, National & Kapodistrian University of Athens, 16462 Athens, GreeceSecond Department of Cardiology and Pulmonary Hypertension Clinic, Attikon Hospital, School of Medicine, National & Kapodistrian University of Athens, 16462 Athens, GreeceSecond Department of Critical Care and Pulmonary Hypertension Clinic, Attikon Hospital, School of Medicine, National & Kapodistrian University of Athens, 16462 Athens, GreeceFirst Department of Critical Care and Pulmonary Hypertension Center, Evangelismos General Hospital, Medical School, National & Kapodistrian University of Athens, 10676 Athens, GreeceBackground: Dobutamine stress echocardiography (DSE) has limited application in systemic sclerosis (SSc). We examined DSE usefulness in revealing pulmonary arterial hypertension (PAH) in selected SSc patients whose resting echocardiography for pulmonary hypertension (PH) was non-diagnostic. Methods: Forty SSc patients underwent right heart catheterization (RHC) and, simultaneously, low-dose DSE (incremental doses up to 20 μg/kg/min). Inclusion criteria were: preserved left and right ventricular (RV) function (tricuspid annulus plane systolic excursion [TAPSE] ≥ 16 mm and tissue Doppler imaging-derived systolic velocity of tricuspid annulus [RVS’] > 10 cm/s), normal pulmonary function tests, and baseline maximal tricuspid regurgitation (TR) velocity of 2.7–3.2 m/s. Results: Of 36 patients who completed DSE, resting RHC diagnosed PAH in 12 patients (33.3%). At 20 μg/kg/min, patients with PAH had higher TR velocity, higher pulmonary arterial pressure measured by RHC, and lower RV inotropic response compared with patients without PAH. A cut-off value of maximal TR velocity >3.1 m/s had a sensitivity of 80%, a specificity of 84.2%, and an accuracy of 82.4% for the detection of PAH. Conclusions: Low-dose DSE has a satisfactory diagnostic accuracy for the early detection of PAH in highly selected SSc patients whose baseline echocardiographic measurements for PH lie in the gray zone.https://www.mdpi.com/2077-0383/10/17/3972dobutamine stress echocardiographypulmonary arterial hypertensionsystemic sclerosis
spellingShingle Loukianos S. Rallidis
Konstantina Papangelopoulou
Georgios Makavos
Christos Varounis
Anastasia Anthi
Stylianos E. Orfanos
Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension
Journal of Clinical Medicine
dobutamine stress echocardiography
pulmonary arterial hypertension
systemic sclerosis
title Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension
title_full Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension
title_fullStr Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension
title_full_unstemmed Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension
title_short Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension
title_sort low dose dobutamine stress echocardiography for the early detection of pulmonary arterial hypertension in selected patients with systemic sclerosis whose resting echocardiography is non diagnostic for pulmonary hypertension
topic dobutamine stress echocardiography
pulmonary arterial hypertension
systemic sclerosis
url https://www.mdpi.com/2077-0383/10/17/3972
work_keys_str_mv AT loukianossrallidis lowdosedobutaminestressechocardiographyfortheearlydetectionofpulmonaryarterialhypertensioninselectedpatientswithsystemicsclerosiswhoserestingechocardiographyisnondiagnosticforpulmonaryhypertension
AT konstantinapapangelopoulou lowdosedobutaminestressechocardiographyfortheearlydetectionofpulmonaryarterialhypertensioninselectedpatientswithsystemicsclerosiswhoserestingechocardiographyisnondiagnosticforpulmonaryhypertension
AT georgiosmakavos lowdosedobutaminestressechocardiographyfortheearlydetectionofpulmonaryarterialhypertensioninselectedpatientswithsystemicsclerosiswhoserestingechocardiographyisnondiagnosticforpulmonaryhypertension
AT christosvarounis lowdosedobutaminestressechocardiographyfortheearlydetectionofpulmonaryarterialhypertensioninselectedpatientswithsystemicsclerosiswhoserestingechocardiographyisnondiagnosticforpulmonaryhypertension
AT anastasiaanthi lowdosedobutaminestressechocardiographyfortheearlydetectionofpulmonaryarterialhypertensioninselectedpatientswithsystemicsclerosiswhoserestingechocardiographyisnondiagnosticforpulmonaryhypertension
AT stylianoseorfanos lowdosedobutaminestressechocardiographyfortheearlydetectionofpulmonaryarterialhypertensioninselectedpatientswithsystemicsclerosiswhoserestingechocardiographyisnondiagnosticforpulmonaryhypertension